Organization | Anika Therapeutics, Inc.

Anika Therapeutics, Inc. Report issue

For profit Phase 2 Phase 3 Phase 4

Founded: Bedford MA United States (1992)

Status: No NME R&D (1992)

Organization Overview

First Clinical Trial

2015

NCT02381652

First Marketed Drug

None

First NDA Approval

None

Last Known Activity

2020

Timeline

NOW

Historical Acquisition Tree

Alternative names

Anika Therapeutics, Inc.

Active Ingredients

Key: Anika Therapeutics, Inc. (0) Acquired (5)

Key: Anika Therapeutics, Inc. (1) Acquired (2)

Key: Anika Therapeutics, Inc. (0) Acquired (1)

Indications